DPH — Dechra Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- £4.40bn
- £4.83bn
- £761.50m
Annual cashflow statement for Dechra Pharmaceuticals, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 39 | 52.2 | 84 | 95.5 | 6.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 79 | 69.8 | 77.7 | 6.5 | 73.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -46 | -29.8 | -88.1 | -68.2 | -106 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 81.8 | 106 | 89.1 | 123 | 63.6 |
| Capital Expenditures | -22.5 | -49.2 | -135 | -77.6 | -30.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -39.4 | -32.3 | -1.3 | -0.7 | -396 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -61.9 | -81.5 | -136 | -78.3 | -426 |
| Financing Cash Flow Items | -0.2 | -1.7 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -20.1 | 119 | -55.1 | -46.1 | 317 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.6 | 147 | -109 | 2.5 | -46.5 |